ERBB2 and breast carcinoma: CTNND1 promotes Her2/ErbB2-induced breast cancer cell migration and invasion by activating Ras-related C3 botulinum toxin substrate 1 (Rac1) and Cell division cycle 42 (Cdc42)26.